🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to observe and explore the efficacy and safety of Penpulima...
Status
Recruiting
Location
Shanghai Ninth People's Hostipal, Shanghai Jiao Tong University School of Medicine
Start Date
2023-10-30
Trial ID
NCT06081673
Treatments Being Tested
This is a randomized, controlled, open-label, multicenter study to evaluate...
Status
Unknown
Location
The First Affiliated Hospital of Anhui Medical University
Start Date
2020-05-20
Trial ID
NCT04385550
Treatments Being Tested
This study is designed to evaluate the efficacy and safety of Anlotinib com...
Status
Unknown
Location
Beijing Hospital
Start Date
2020-03
Trial ID
NCT04291248
TQB3602 is a kind of proteasome inhibitor, AK105 is an anti-programmed cell...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2022-07-29
Trial ID
NCT05333276
Treatments Being Tested
This is a prospective, open-label single-arm, exploratory, two-stage design...
Status
Unknown
Location
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Start Date
2021-09
Trial ID
NCT05033587
Treatments Being Tested
This is a randomized, controlled, open-label, multicenter study to evaluate...
Status
Active Not Recruiting
Location
The First Affiliated Hospital of Bengbu Medical College
Start Date
2020-08-11
Trial ID
NCT04344158
Treatments Being Tested
TQB2223 is a recombinant, fully human antibody that binds to lymphocyte act...
Status
Terminated
Location
Affiliated Cancer Hospital of Harbin Medical University
Start Date
2024-05-30
Trial ID
NCT06320080
Treatments Being Tested
AK105 is a humanized monoclonal antibody that specially binds to PD-1. Anlo...
Status
Unknown
Location
Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2020-05-09
Trial ID
NCT04203719
This trial is a multicenter, prospective, single-arm exploratory clinical s...
Status
Recruiting
Location
Department of radiotherapy,The First Bethune Hospital of Jilin University
Start Date
2022-01-25
Trial ID
NCT05260671
Treatments Being Tested
This is an open label, randomized, phase Ⅱ, multi-cohort study to treat sub...
Status
Recruiting
Location
Jiangsu Province Hospital
Start Date
2022-03-16
Trial ID
NCT05494060
Treatments Being Tested